"Booster" interventions to sustain increases in physical activity in middle-aged adults in deprived urban neighbourhoods: internal pilot and feasibility study by Scott, E.J. et al.
promoting access to White Rose research papers 
   
White Rose Research Online 
eprints@whiterose.ac.uk 
 
 
 
Universities of Leeds, Sheffield and York 
http://eprints.whiterose.ac.uk/ 
 
 
 
This is a copy of the final published version of a paper published via gold open access 
in BMC Public Health 
 
This open access article is distributed under the terms of the Creative Commons 
Attribution Licence (http://creativecommons.org/licenses/by/3.0), which permits 
unrestricted use, distribution, and reproduction in any medium, provided the 
original work is properly cited. 
 
White Rose Research Online URL for this paper: 
http://eprints.whiterose.ac.uk/88386 
 
 
 
 
 
Published paper 
 
Scott, E.J., Dimairo, M., Hind, D., Goyder, E., Copeland, R.J., Breckon, J.D., Crank, 
H., Walters, S.J., Loban, A. and Cooper, C.L. (2011) "Booster" interventions to 
sustain increases in physical activity in middle-aged adults in deprived urban 
neighbourhoods: internal pilot and feasibility study. BMC Public Health, 11 (129 ) 
10.1186/1471-2458-11-129 
 
 
RESEARCH ARTICLE Open Access
“Booster” interventions to sustain increases in
physical activity in middle-aged adults in
deprived urban neighbourhoods: internal pilot
and feasibility study
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Abstract
Background: Systematic reviews have identified a range of brief interventions which increase physical activity
in previously sedentary people. A randomised controlled trial is needed to assess whether providing
motivational interviewing, three months after giving initial advice, sustains physical activity levels in those
who recently became physically active. This paper reports the results of an internal pilot study designed to
test the feasibility of the study in terms of recruitment, per protocol delivery of the intervention and retention
at three months.
Methods: Participants were: aged 40-64 years; resident in deprived areas of Sheffield, UK; and, had recently
become physically active as a result of using a brief intervention following an invitation from a mass mailout.
Interventions: Motivational Interviewing ‘boosters’ aimed at sustaining change in physical activity status delivered
face-to-face or over the telephone compared with no further intervention. Outcomes of the feasibility study:
recruitment of 60 participants from mailout of 3,300; retention of 45 participants with 3-month follow-up
accelerometry measurements; 70% of those randomised to boosters receiving intervention per protocol. Sample
size and power were recalculated using the accelerometry data collected.
Results: Forty-seven participants were randomised (78% of the feasibility target); 37 participants were retained
at three months, 29 with at least four days of accelerometry data (64% of the feasibility target); 79% of those
allocated boosters received them per protocol (surpassing the feasibility target). The proposed sample size of
600 was confirmed as appropriate and power is expected to be sufficient to detect a difference between
groups.
Conclusions: The main study will continue with the original recruitment target of 600 participants but to ensure
feasibility, it is necessary to increase recruitment and improve the numbers of those followed-up who have
evaluable data. Strategies will include increasing the number of initial invitations sent out and improving the
training of research assistants and participants in the positioning of the accelerometer.
Trial Registration: ISRCTN: ISRCTN56495859, ClinicalTrials (NCT): NCT00836459
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2Clinical Trials Research Unit, University of Sheffield, Regent Court, 30 Regent
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Background
Participation in regular physical activity is associated
with reductions in all-cause mortality [1] and decreased
risk of cardiovascular disease [2] and some forms of
cancer [3]. Additionally, there is a role for regular exer-
cise in both the prevention and treatment of hyperten-
sion [4], type 2 diabetes [5] and obesity [6]. From a
psychological perspective, regular physical activity has
been shown to relieve anxiety [7], improve mood [8]
and reduce depressive symptoms [9]. The majority of
the British population, however, are not active enough
to experience these benefits [10]. The primary aim of
intervention programmes is to encourage participants to
increase their activity sufficiently to meet the current
recommended levels for health benefit [11].
A recent systematic review established that brief inter-
ventions in primary care can increase physical activity
levels [12] and identified a sufficient evidence base for
the UK National Institute of Health and Clinical Excel-
lence (NICE) to recommend their use [13]. The review,
however, also identified specific evidence gaps, particu-
larly with regard to the value of follow up beyond three
months for the longer term maintenance of physical
activity. The lack of evidence relating to follow-up is
particularly important as the literature suggests that
approximately half of those who initiate a physical activ-
ity program relapse and return to their previous seden-
tary lifestyle within six months [14]. Yet maintenance of
increased physical activity levels is essential to achieve
the reported health benefits.
The Sheffield Physical Activity Booster Trial assesses
the effectiveness and cost-effectiveness of Booster inter-
ventions to help people who have recently become more
active maintain their increased physical activity levels. It
is a three-arm, open-label, parallel group, randomised
controlled trial (RCT) with a feasibility study. It com-
pares two different intensities of a Motivational Inter-
viewing (MI)[15] ‘booster’ intervention against no
further intervention in middle-aged adults, aged 40 to
64, who have already increased their physical activity
levels following a brief intervention. MI is one of the
behaviour change interventions recommended by NICE
for health promotion [16]. The purpose of the booster
sessions is to help participants to sustain their physical
activity levels and prevent relapse. The brief intervention
involves provision of an interactive DVD based on a MI
approach that is directive, person-centred and replicates
the style of other successful behaviour change pro-
grammes [17] and was underpinned by all four con-
structs of the Trans-Theoretical Model of behaviour
change [18]. All interventions are delivered by trained
facilitators whose competence was independently
assessed to ensure consistent delivery using a treatment
fidelity framework [19,20].
The study is being carried out in two phases. An
internal pilot and feasibility study has been undertaken
in the first year to allow refinements to the sample size
as well as to assess the feasibility of trial recruitment
plans and the proposed interventions. This will be fol-
lowed by the main study, which will evaluate the effec-
tiveness and cost-effectiveness of “’mini” and “full”
booster sessions, as an adjunct to a brief intervention, in
sustaining physical activity in middle-aged adults. This
paper only describes the results of the internal pilot and
feasibility study.
Methods
Full details of the research protocol have been published
in another paper [21].
Participants and setting
For the feasibility study, the local health services (NHS
Sheffield) sent 3,300 letters with pre-paid reply cards to
residents aged 40-64 yrs in one of the Enhanced Public
Health Program (EPHP) areas of the city inviting them
to enrol in a programme to help them get more physi-
cally active. This programme involved a “brief interven-
tion” (interactive DVD), which is consistent with NICE
guidance on physical activity and behaviour change
interventions [13,16]. Although there are approx. 53,000
residents aged 40-64 yrs in the EPHP areas, this initial
recruitment mail-out, represents approximately 10% of
the 30,000 expected to be contacted for the main trial.
All respondents’ current physical activity levels were
assessed; those not achieving the current recommended
activity level (at least 30 minutes of moderate activity on
at least 5 days [11]) and wishing to have support to
become more active were eligible for the brief interven-
tion. As the eligible respondents were sedentary at first
contact, any increase in physical activity, irrespective of
intensity, is likely to be beneficial. Thus, the DVD
focussed on increasing activity in general, rather than
emphasising moderate or strenuous activity specifically.
Three months after initially receiving the brief interven-
tion, DVD recipients’ physical activity levels were re-
assessed; those who had increased their physical activity
level by at least 30 minutes of moderate or vigorous
activity per week and were capable of giving written
informed consent were invited to participate in the fea-
sibility trial. Due to the practicalities of screening large
numbers of respondents for both the brief intervention
and subsequent trial, a self-report measure of physical
activity, the Scottish Physical Activity Questionnaire
(SPAQ) [22], was used at both of these stages.
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Interventions
Participants were randomly allocated to one of three
groups:
1. “Full booster": two 20-30 minute face-to-face physi-
cal activity consultations using MI in a community set-
ting, at one month and two months after randomisation,
which aimed to promote and sustain change in physical
activity status. This included an exploration of barriers
and motives to change, decisional balance, agenda set-
ting, action planning and relapse prevention;
2. “Mini booster": two 20-minute telephone based phy-
sical activity consultations (using MI) at one month and
two months after randomisation. The mini-booster ses-
sions also aimed to promote and sustain increased phy-
sical activity levels and focussed on exploration of
relevant PA experience and commensurate action plan-
ning; or,
3. a control group, who received no additional support
between randomisation and three month assessment.
The treatment fidelity and acceptability of the inter-
vention will be reported elsewhere. In this report, the
feasibility of the intervention is only considered in terms
of intervention adherence (see below).
Objectives
The primary objective of the main study is to determine
whether physical activity, measured by accelerometry
three months after randomisation (six months after a
brief intervention), is significantly increased in partici-
pants allocated to two intervention groups ("full” or
“mini” booster) compared to participants allocated to a
control group. Both this and the other objectives of the
main study are described in detail elsewhere [21].
The primary objective of the pilot study, however, is
to assess the feasibility of both trial recruitment plans
and the proposed interventions. Secondary objectives
are:
1. To estimate the mailout response rate which is the
proportion of individuals who responded, were contact-
able and were eligible for the brief intervention;
2. To estimate the effectiveness of the brief interven-
tion, which is the proportion of recipients who increased
their physical activity after 3 months and were eligible
for the RCT;
3. To estimate the consent rate which is the propor-
tion of eligible recipients who consented to participate
and be randomised to any of the three arms;
4. To estimate the proportion of participants rando-
mised to booster interventions who received the inter-
ventions per protocol, defined as receiving both of the
intended face to face or telephone sessions.
5. To estimate the proportion of participants who
provided primary outcome data 3 months post
randomisation.
6. To verify the accuracy and completeness of the
data. This routine data management activity was not a
protocol-specified outcome, but is reported here because
the funding body and trial steering committee requested
a full report due to concerns about the usability of one
of the patient reported outcome measures, the Exercise
Evaluation Randomised Trial (EXERT) questionnaire
[23].
Outcomes
The primary outcome for the main study is objective
measurement of physical activity using Actiheart
(CamNtech, Cambridge, UK), which provides both
accelerometery-derived physical activity counts (PAC)
per week and mean total energy expenditure (TEE) in
kilocalories (kcal) per day. Secondary outcome measures
for the main study are reported in detail elsewhere [21]
but include self-reported physical activity using the
SPAQ [22] and Exercise Evaluation Randomised Trial
(EXERT) questionnaire [23].
The prospectively defined success criteria for the feasi-
bility study were:
1. To recruit and randomise at least 60 participants to
the pilot trial (10% total sample size required for main
study) and for at least 45 of these (75% retention) to
provide 3 month follow-up measurements including
accelerometry on the basis of an initial mail-shot to
3,000 individuals;
2. At least 70% of those randomised to the booster
interventions receive the interventions per protocol,
confirming the feasibility of the intervention;
3. On the basis of the pilot primary outcome (accel-
erometry) data collected, the sample size for the main
trial will be re-calculated. The trial will not proceed if
the revised sample size calculation suggests a total sam-
ple size notably greater than 600 will be required.
Assuming the protocol and intervention remain
unchanged, the participants recruited during the feasibil-
ity phase will be included in the full trial population.
Other objectives of the pilot trial were to obtain an
estimated standard deviation for the primary outcome
from the feasibility study data, to perform a power cal-
culation for the main study for both mean TEE (kcal)
per day and PAC per week, assuming a fixed sample
size of 600 for the main comparison (combined inter-
ventions versus control), and to verify the accuracy and
completeness of the data collected, assessed through
10% source data verification and prospectively defined
as an acceptable error rate of 0.5%.
Proposed sample size for the main study
The primary outcome for the main study is seven-day
accelerometric assessment of physical activity (PAC per
week) at three months post-randomisation. The original
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sample size calculation assumed that a mean difference
of 400,000 PAC per week between the intervention and
control groups at three months was the smallest clini-
cally and practically important difference and that the
SD of this outcome was 1.2 million counts per week.
Hence with 450 participants (300 intervention: 150 con-
trol), the main trial was determined to have 90% power
to detect this mean difference or greater between the
“booster” and control arms as statistically significant at
the 5% (two-sided) level using a two independent sam-
ples t-test. With 300 participants in the booster inter-
vention (150 mini: 150 full booster) the trial would also
have approximately 80% power to detect a similar mean
difference of 400,000 counts per week between the two
booster arms as statistically significant at the 5% (two-
sided) level using a two independent samples t-test.
Assuming an approximate 25% loss to follow-up by
three-months, we proposed to recruit and randomise
200 participants per intervention group to give a total
sample size of 600 participants.
Statistical methods
The intention-to-treat (ITT) dataset included all partici-
pants who: (1) were randomised according to the alloca-
tion schedule (ignoring non-compliance, protocol
deviations and withdrawals); and, (2) had a valid three-
month accelerometry data defined as at least four com-
plete days (out of seven) data. To minimise missing data,
the “auto-fill” option on the Actiheart software, which
fills gaps of up to two hours with the average values cal-
culated from the recorded portion of the same day, was
used. Days with more than two continuous hours of
missing data, were classified as incomplete. Where miss-
ing data was determined to be because the participant
had taken the accelerometer off to sleep, “sleeping”
values were imputed. The results are reported based on
standardised daily measurements (≥4 complete days).
The mean difference and standard deviations were
used to estimate a minimum clinically important differ-
ence (MCID) based on 1/3 of the SD of physical activity
counts per week. The sample size for the main study
was recalculated, using the standard deviation of PAC
per week from the pilot study and the original standar-
dised effect size of 0.33 from initial sample size calcula-
tion. A power calculation for the main study was
performed on both the original (PAC per week) and
proposed (TEE per day) primary endpoints, based on
their respective MCID and observed standard deviation
from the feasibility study. This was only done for the
main comparison (combined interventions versus con-
trol). When re-estimating the sample size using data
from an internal pilot study the revised sample size esti-
mate either stays the same or increases, it cannot be less
than the original estimate [24,25].
Ethical aspects
North Sheffield Research Ethics Committee granted
ethical approval on 11th February 2009 and informed
consent was conducted as per the main study.
Results
Recruitment
Figure 1 shows the flow of participants through the feasi-
bility study. Of the 3,300 people invited to apply for the
interactive DVD in May/June 2009, 329 responded and
277 of these were contacted successfully. Of those con-
tacted, 188 were achieving less than 30 minutes of mod-
erate activity on at least 5 days a week, and so were
eligible for the brief intervention (interactive DVD) by
September 2009. Of those sent the DVD, 104/188 were
still contactable after 3 months and of these, 82/188
(44%) had successfully increased their physical activity,
making them eligible for the feasibility study. Forty-seven
of the 82 (57%) eligible participants were recruited, con-
sented and randomised to the feasibility study in Novem-
ber/December 2009, against a target of 60 participants,
which translates as a ratio of 0.78 for the planned to
actual recruitment targets. The main reason for non-par-
ticipation given by eligible participants who declined to
be randomised was that they were not interested in receiv-
ing further support to stay active (n = 18). Other reasons
included lack of time (n = 6), family reasons (n = 3) and
health concerns (n = 1). The remaining seven gave no
specific reason for choosing not to be randomised.
Baseline population characteristics
Table 1 shows the demographic characteristics of rando-
mised participants. The figures for the baseline increase in
physical activity show that some participants decreased
their physical activity levels, suggesting that they may not
have been eligible for the trial. Indeed two participants did
not show a 30 minute increase in activity on the SPAQ at
pre-trial screening. Both of these individuals, when they
completed their initial SPAQ, at brief intervention screen-
ing, indicated that they had done more physical activity in
the last week than normal. After accounting for the addi-
tional activity, both candidates were deemed to have
increased their average physical activity levels by 30 min-
utes or more and were considered eligible.
Validity of data and accuracy of the data entry
Acceptable error rates for data entry were prospectively
defined as 0.5% in line with industry standards for phase
I-III clinical trials. Error rates for two patient-reported
outcome measures were initially considered unaccepta-
ble: the SPAQ (error rate 6.5%) and EXERT (error rate
1.3%). Providing the research assistants with additional
training regarding data entry procedures eliminated the
error rates for the SPAQ, but not for the EXERT, where
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error rates remained unacceptably high (2.1%). The
errors are largely random and unlikely to be resolved by
further training.
Evaluable data at 3 months of follow-up
Thirty-seven (79%) of the 47 randomised participants had
follow-up data at 3 months. Of the remaining ten, eight
withdrew from the study, one died and one was lost to
follow-up. Thirty-four (92%) of the 37 participants who
provided 3 month data had at least one complete day of
accelerometry data (two missing due to monitor set-up
error and one removed due to skin reaction). Twenty-
nine participants (62% of those randomised) had at least
4 complete days of accelerometry data (see Figure 1).
Had at least 4
complete days of
Actiheart data
n=16
Had at least 4
complete days of
Actiheart data
n=7
Had at least 4
complete days of
Actiheart data
n=6
Less than 4
complete days of
Actiheart data
n=6
Less than 4
complete days of
Actiheart data
n=1
Less than 4
complete days of
Actiheart data
n=1
Followed up after 3
further months
n=22
Followed up after 3
further months
n=8
Completed 3
months evaluation
n=7
Not followed up
after 3 further
months
n=4
Not followed up
after 3 further
months
n=2
Not followed up
after 3 further
months
n=4
Allocated to control
(n=26)
Allocated to
mini-booster
(n=10)
Allocated to
full-booster
(n=11)
Consented and randomised
n=47 (57%)
Unwilling to be randomised
n=35 (43%)
Increased physical activity levels;
eligible for main study (RCT)
n=82 (100%)
Did not increase physical activity
levels; ineligible for main study
(RCT)
n=22
Contactable after 3 months
n= 104
Eligible; sent brief intervention
n=188
Not contactable
n=52
Contactable; screened for brief
intervention eligibility
n=277
Non-responders
n=2,971
Responders
n=329
Ineligible
n=89
Reasons:
1. Too active (n=83)
2. Too old (n=5)
3. Other (n=1): health concerns
Postal invitation to use brief
intervention
n= 3,300
Not contactable after 3 months
n=84
A
B
C
D
E
F
G
H
I
J
K
L
M
Figure 1 Participant recruitment flowchart.
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Interventions received per protocol
Of the 21 participants who were randomised to the two
booster interventions, 18 (86%) received their interven-
tions as per protocol (10 and 8 in mini and full booster
respectively) against a target of at least 70%.
Summary of outcome measures using the Actiheart
The original sample size calculation of 450 participants
with valid outcome data at 3 months post-randomisa-
tion, was based on detecting a standardised effect size of
0.33 or a mean difference of one-third of a standard
deviation in the outcome measures between the booster
and control groups. This equates to an estimated mean
difference between the booster and control groups,
based on the the observed standard deviation from the
feasibility study, of 34,465 PAC per week and 102 kcal
per day for TEE. For the TEE outcome a difference of
102 kcal is approximately 5% of mean TEE per day.
Table 2 gives a summary of the Actiheart outcome mea-
sures, PAC and TEE, for the 29 patients with at least 4
complete days of accelerometry measurements. The
mean PAC per week was 285,918 (SD 103,394) and the
mean TEE per day was 2125 kcal (SD 305 kcal).
Sample size re-calculation
The original sample size calculation assumed that physi-
cal activity would be measured using a simple hip-
mounted accelerometer. It was also assumed that a
mean difference of 400,000 PAC per week between the
intervention and control groups at three months was
the smallest clinically and practically important differ-
ence and that the SD of this outcome was 1.2 million
counts/per week. Hence with 450 participants (300
intervention: 150 control), the main trial was determined
to have 90% power to detect this mean difference or
greater between the intervention and control arms as
Table 1 Baseline characteristics of randomised participants
Variable n mean sd minimum maximum
Age (yrs) 47 56.2 6.7 41.1 65.2
SPAQ Change* 47 245.4 247.9 -30.0 1300.0
Height (m) 47 1.7 0.1 1.5 1.9
Weight (kg) 47 83.8 19.1 52.0 160.0
BMI (kg/m2) 47 30.4 5.6 20.3 46.0
n %
Sex Male 15 32
Female 32 68
47 100
Martial Single 2 4
Status Married 36 77
Co-habiting 3 6
Divorced/Separated 4 9
Widowed 2 4
47 100
Ethnicity White-British 46 98
1 2
47 100
Employment Part-time 12 26
Status Full-time 14 30
Retired 13 28
Looking after family/home 2 4
Permanently sick/disabled 2 4
Temporarily sick/disabled 1 4
Unemployed actively seeking work 1 2
None of the above 1 2
47 100
* Difference between SPAQ at first contact and three months later (one week before randomisation). Two patients recorded a decrease in physical activity over
3 months, as measured on the SPAQ, of 25 and 30 minutes respectively. See text for explanation as to their inclusion.
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statistically significant at the 5% (two-sided) level using a
two independent samples t-test. Assuming an approxi-
mate 25% loss to follow-up by three-months, it was pro-
posed to recruit and randomise 200 participants per
group giving total sample size of 600. Table 2 shows
that the Actiheart accelerometer measures physical
activity counts per week on a different scale of magni-
tude to a simple hip mounted accelerometer with a con-
siderably lower mean and standard deviation.
When re-estimating the sample size using data from
an internal pilot study the revised sample size estimate
either stays the same or increases (it cannot be less than
the original estimate) [25,26]. The original sample size
calculation of 450 participants with valid outcome data
at 3 months post-randomisation, was based on detecting
a standardised effect size of 0.33 or a mean difference of
one-third of a standard deviation in the outcome mea-
sures between the intervention and control groups. This
equates to an estimated mean difference between the
Booster and Control groups, based on the observed
standard deviation from the feasibility stage of 34,465
PAC per week and 102 kcal per day for TEE.
To have a 90% power of detecting a mean difference of
102 kcal in mean TEE per day is between the groups
would require 426 participants in total with evaluable data
(control = 142; intervention = 284). Similarly, the total
required sample size under the above conditions to detect
a mean difference of a 34,465 PAC per week is 429. There-
fore since the re-estimated sample size, of around 430
participants, is lower than the original estimate of 450
participants the trial will proceed with the original sample
size estimate of 450 participants with evaluable data.
Power estimation
The original sample size calculations assumed an
approximate 25% loss to follow-up by three-months,
and proposed to recruit and randomise 200 participants
per intervention group giving a total sample size of 600
participants, to give 450 participants with evaluable data.
The feasibility study, however, observed an attrition rate
of approximately 38% with only 62% (29/47) randomised
participants having complete accelerometry data. If this
attrition rate is repeated in the main study then with an
initial sample size of 600 and an attrition rate of 40%
and hence 360 participants with valid 3-month post
randomisation accelerometry data then the study would
have 85% power to detect a mean difference of 102 kcal
in TEE between the groups, if such a difference truly
exists. If this 40% attrition rate is observed in the main
study then we believe that the marginal loss in power is
acceptable and propose to carry on recruiting and ran-
domise 200 participants per intervention group to give a
total sample size of 600 participants.
Serious adverse events
There were two serious adverse events, neither of which
were considered to be related to the intervention. In the
first, a participant died of Myocardial Infarction and
Ischemic Heart Disease prior to receiving the interven-
tion. In the second, a participant was admitted to hospital
with a suspected Myocardial Infarction. Symptoms came
on at rest. Tests revealed that it was not a Myocardial
Infarction, and was most likely to be angina-related pain.
Discussion
Summary of findings
Forty-seven participants were recruited (78% target),
thirty-seven were retained at three months and 29 of
these provided at least four days accelerometry data
(64% target). The number receiving the Booster inter-
ventions per protocol surpassed the feasibility target and
data error rates were within acceptable limits, with the
exception of the EXERT questionnaire.
From the data recorded, the standard deviation is esti-
mated to be 103,394 PAC per week or 305 kcal per day
for TEE and the sample size has been recalculated. With
600 randomised participants and 30% loss to follow-up
the study will have approximately 90% power to detect a
mean difference of 102 kcal per day in TEE between the
groups as statistically significant at the 5% two-sided level.
The observed attrition rate in the pilot study was, however,
higher than this at 38%. With an initial sample size of 600
and assuming an attrition rate of 40%, and hence 360 par-
ticipants with valid accelerometry data at three months
then the study would have 85% power to detect a mean
difference of 102 kcal in TEE between the groups.
Improving recruitment and retention
The fact that 82 out of the 104 DVD recipients who
were screened after three months had increased their
Table 2 Summary of primary outcome measures at 3-months post-randomisation
Outcome N a Min max mean Sd p25 Median p75 Effect size b
PAC per week 29 109,008.0 633,024.0 285,917.9 103,394.0 228,528.0 269,568.0 329,184.0 34,464.7
Mean TEE (KCal) per day 29 1572.0 2761.7 2124.9 304.6 1917.7 2091.6 2300.0 101.5
a only participants with at least 4 complete days (8 excluded; 5 had less than 4 complete days and remaining 3 had no Actiheart data at 3 months).
b Effect size based on (1/3) of the estimated standard deviation (sd) from the data.
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physical activity and were eligible for the study is pro-
mising. But, as only 47 were consented and randomised,
strategies to improve recruitment are clearly required.
The initial invitation to use the brief intervention (DVD)
is being extended to all 40-64 year olds resident in
EPHP areas giving a pool of 53,000 rather than only
30,000 residents (as originally intended) from which to
draw (Figure 1 Box A). Extrapolating from the pilot data
and with other things being equal, we would now expect
the proposed mailout to 30,000 residents to result in
420 (95% CI: 380 to 570) participants randomised to
the main trial (Figure 1 Box M), somewhat short of
the proposed 600. With a mailout of 50,000, however,
we would expect to be able to recruit 700 (95% CI:
550 to 950) participants. We have also increased the
intensity with which the study is promoted. In the
pilot area, the study was implemented without NHS or
community-based support, awareness raising or publi-
city. Knowledge of the brief intervention’s availability
was communicated purely by one-to-one postal con-
tact. In future areas, the invitation letters are being
supported by local awareness raising involving EPHP
area leads and other NHS links, community activists
and wider media promotion.
A large minority (30%) of those who responded to the
initial invitation and were contactable (Figure 1 Box F)
were ineligible for the brief intervention almost exclu-
sively because they were already too active. While it is
too late to alter the recruitment materials for this study,
any future trial attempting to identify people with
sedentary lifestyles might consider incorporating a single
item measure of current physical activity into the reply
card, to avoid unnecessary telephone screening.
Further down the CONSORT diagram, many of
those who were sent the brief intervention were not
contactable for pre-trial screening after three months
(Figure 1 Box H). To address this, during initial
screening preferred method of contact is now con-
firmed and SMS messaging or e-mail offered, as well
as post and telephone.
The refusal of consent by 43% of those eligible to be
randomised is unsurprising considering the recruitment
yield of prevention trials generally, e.g. Spilker and Kra-
mer cite typical recruitment yields of only 1% to 6%
[27]. Putting recruitment figures in context is not easy
as many trial reports do not record how many people
were invited to participate, only how many were
screened and randomised. For instance, the EXERT trial,
which evaluated GP referral for different exercise pro-
grammes, report randomising 949 out of 1105 people
who contacted the team, but did not record the number
of patients who were advised by their GPs to take part
in the programmes, but did not wish to do so [23].
Korde eventually randomised 29 out of 352 women
(8.2%) at risk of breast cancer who initially expressed
interest in the study; it is not known how many women
the team initially contacted [28]. Similarly, the BRUM-
CHF trial evaluating home-based exercise rehabilitation
for patients with congestive heart failure screened 1639
patients, invited 642 (39.2%) to participate and rando-
mised 169 (10.3%) [29]. The SMART trial, evaluating
different modes of self-monitoring on short- and long-
term weight loss, finally randomised 210/704 (29.8%)
originally screened for eligibility by phone but again
there is no information about the numbers contacted in
the original mailout [30]. The numbers in these studies
further suggests that converting eligible to randomised
participants is unlikely to be easy. There is little differ-
ence between the recruitment rates of individual
research assistants working on Booster, so training is
unlikely to be an issue. Where reasons have been given
for non-consent, the most frequently cited is lack of
interest in further support to stay active.
Of the 47 participants randomised into the trial, ten
did not complete three month follow up assessments.
Eight of these participants had withdrawn prior to the
three month assessment, with the most common reason
cited as being too busy to continue (n = 5). Strategies to
minimise numbers withdrawing are needed. During the
feasibility phase, both intervention and assessment ses-
sions were being delivered at venues local to the partici-
pant’s residence with appointments scheduled at the
participant’s convenience, including in the evening and
at weekends. During the main trial, however, sessions
will also be offered at venues which are close to large
employment hubs. It is hoped that this wider choice of
venue will make the sessions more readily accessible to
participants. Although it is not possible to abbreviate
the intervention, it may be possible to shorten the
assessment visits for those participants who express con-
cerns about time constraints, e.g. by mailing question-
naires out in advance, to be returned at a shortened
assessment visit.
Three Actiheart devices were returned with no usable
data Two of these cases were due to set-up error result-
ing in the device not recording. This is a training issue
and all research assistants will be given refresher train-
ing on programming the devices prior to the main trial
to minimise the risk of similar set-up errors occurring
in future. The remaining device with no data was due to
removal soon after fitting due to skin irritation. This is
an acknowledged issue in research using Actiheart
devices: during fitting the participant’s skin is cleaned
and abraded to remove the top layer of skin prior to the
application of the two self-adhesive ECG pads which the
Actiheart device attaches to. The process of cleaning
and abrasion combined with the presence of the ECG
pads can cause skin irritation in some participants.
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Previous studies using Actiheart devices have reported
skin irritation rates in up to 12% participants for proto-
cols requiring seven days continuous wear [31]. Five
devices had less than four full days data; there was no
specific reasons were identifiable for this. As some initial
data was recorded in all cases and the Actihearts all
recorded for the full seven days, it is likely that partici-
pants removed the monitors before the end of the moni-
toring period but did not report that fact. Examination
of the assessment records did not reveal any systematic
failure to provide full data sets, e.g. due to a particular
research assistant delivering instructions. During the
main trial, however, additional emphasis will be placed
on ensuring that participants understand the importance
of wearing the monitor for the full monitoring period.
Spare ECG pads will also be provided in case shorter
periods of wear were due to the original set of pads
becoming detached from the skin.
Reach and representativeness
Glasgow and colleagues define ‘reach’ as an individual-
level measure of participation, which refers to the per-
centage and risk characteristics of persons who receive
or are affected by a policy or program [32]. A casual
glance at the CONSORT flow diagram (Figure 1), may
lead to the conclusion that this intervention is lacking
the reach necessary for an effective health behaviour
intervention. Study eligibility criteria, however, means
that the recruitment yield should be understood as 57%
of those having received and benefited from a brief
intervention (Figure 1 Box K) rather than 25% of those
eligible for the brief intervention (Box G), or .4% of
those originally contacted (Box A).
The other concern is whether the study population is
representative of target populations. The high number
of women (68.1%) in the trial population reflects those
who were eligible for the brief intervention (Figure 1
Box G, 68.5% female) and those who came forward for
the brief intervention (Figure 1 Box E: 63.5% female)
rather than the target population of the pilot area, High
Green (50.5% female). The age distribution of the pre-
trial population (Figure 1 Box E: n = 277) was not only
skewed but differed markedly between genders. Women
showed a linear increase in the response to the initial
mailout with increasing age, such that almost twice as
many women in the 60-64 years bracket responded as
those aged 40-44 years. On the other hand, the response
to the mailout among men was bimodal with peaks in
the 40-44 years and 60-64 years categories and the few-
est respondents from the 50-54 years category. High
Green residents are predominantly White-British
(97.4%) and this seemed to be reflected in both our con-
tactable respondents and those eligible for the DVD,
although no ethnicity data was collected during
screening as it was not relevant to eligibility. Similarly,
no income data was collected on the pre-trial popula-
tion. Concerns expressed by local public health leads,
however, that a mass mailout would attract people from
the relatively wealthy periphery rather than those in
greater need living in the more deprived core of the
neighbourhood appear unwarranted; an informal map-
ping exercise revealed a relatively even spread over the
pilot area.
Proposed change of primary outcome
As mentioned above, a change in how the primary out-
come, physical activity, is quantified in this trial has
been proposed and was presented to representatives of
the funding body prior to three month data collection
or analysis for the pilot study. The proposal was put to
independent scientific review and conditionally agreed
before the statistical analysis plan for the feasibility ana-
lysis was signed off and analysis commenced. Further
details of the rationale behind this change are available
from the lead author and a brief summary has been
published elsewhere [21].
Data quality and the EXERT questionnaire
There were problems with the questionnaire adopted
from the EXERT trial [23] with persistent, mostly ran-
dom, errors occurring in the data despite retraining of
research assistants. The EXERT trialists had adapted the
this questionnaire from another physical activity trial in
West London [33], which itself had been adapted from a
self-administered seven day recall questionnaire used in
other community intervention studies [34]. Although
used to measure changes in physical activity over time
in EXERT, the original purpose of the West London
questionnaire was to classify individuals as active or
inactive vis-à-vis existing recommendations on physical
activity and health [33]. Discussions with the EXERT
trial team established that a simpler questionnaire
would have been preferable for both trial participants
and the analysis team. Furthermore, some elements did
not look reliable in the EXERT trial and not all of the
data collected was used in the final analysis (Julia
Critchley and Tony Isaacs, personal communications).
Thus, the Booster trial steering committee have advised
abandoning the EXERT questionnaire.
Conclusions
Although the response to the brief intervention was pro-
mising, there were problems converting eligible indivi-
duals to randomised participants. Retention of sufficient
participants with evaluable data was also an issue.
Changes in recruitment and retention strategies are
needed to ensure adequate numbers are randomised and
retained. There are also some issues surrounding data
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collection to address. The sample size re-calculation
confirmed the original sample size of 600 to be appro-
priate and that, with 600 participants, the trial will still
have sufficient power to detect a significant difference
between groups despite the greater than anticipated
attrition rate.
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